Denosumab is a relatively recent drug on the market, approved by the US Food and Drug Administration (FDA) under the trade name of Prolia for postmenopausal women with risk for osteoporosis… more»
In general, the NEWSTART program does not promote supplementation unless there is a documented deficiency and supplementation can be conducted under the guidance of a physician. With this… more»
Q. Are prescribed medications such as Calcium, Vitamin D, and Alendronate necessary to reduce osteoporosis fracture risk?
Are the prescribed medications necessary? Well that is a very good question in light of the western lifestyle. If you go to rural China or Japan where the women eat lots of soy products such… more»